Patients with cancer have an increased risk of developing VTE. Find out why this is the case and learn more about the steps that can be taken to prevent this common complication.
The relationship between cancer and venous thromboembolism (VTE) is well-established. Test your knowledge of the clinical risk factors for VTE in cancer and find out what can be done to prevent this common and life-threatening complication. Our eLearning will also give you the opportunity to improve your understanding of the importance of screening for cancer in patients with unprovoked VTE and potentially save lives.
Venous thromboembolism risk in cancer
|Closing questions||Test your knowledge||5 mins|
|Introduction||Introduction to eLearning module||5 mins|
|Section 1||Pathophysiology||10 mins|
|Section 2||Prevalence and incidence||5 mins|
|Section 3||Cancers with higher risk of VTE||8 mins|
|Section 4||Thrombotic events and occult malignancy||5 mins|
|Section 5||Summary||2 mins|
On completion of this module participants should have a good understanding of:
- why patients with cancer are at higher risk of venous thromboembolism (VTE) compared to the general population
- which cancer types are associated with the highest risk of VTE and how individual risk can be assessed
- how the prevalence and incidence of VTE in patients with cancer compares to the general population
- the importance of cancer screening patients with unprovoked VTE
Evaluation questions will be asked at the end of the module. These are designed to test your knowledge and consolidate your learning.
Developed by EPG Health for Medthority. This content has been developed independently of the sponsors who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.